Irtaza Khan
Papers
1
Total Citations
10
H-Index
1
About
Irtaza Khan is a clinician-researcher whose work focuses on improving the accuracy of renal tumor assessment and optimizing active surveillance strategies for kidney cancer patients. His most-cited study, published in 2017, directly addresses a critical clinical question: how do computed tomography (CT) and magnetic resonance imaging (MRI) compare in measuring renal tumor size? By analyzing a multi-institutional database of 807 patients who underwent robotic partial nephrectomy, Khan demonstrated that MRI provides more accurate predictions of final pathologic tumor size than CT—a finding with immediate implications for patients on active surveillance, where precise measurement is essential for safe monitoring. This work has accumulated 10 citations, reflecting its practical value in urologic oncology. Khan’s contributions help bridge the gap between imaging accuracy and clinical decision-making, offering evidence that can reduce unnecessary interventions while ensuring timely treatment when needed. His research exemplifies how rigorous comparative analysis of diagnostic tools can directly improve patient care in nephrology and oncology.
Research Focus
Key Achievements
Top Papers
- 1